Skip to main content

DayOne Tech supports three medtech startups

| News

DayOne Tech supports three medtech startups


DayOne, the healthcare innovation initiative from Basel Area Business & Innovation, has started its medtech accelerator in the canton of Jura with three startups. CNS Therapy, Moonlight AI, and CryoThermo 4.0 will receive access to coaching, the ecosystem, office space, and funds over twelve months.

Three medtech startups began their year-long journey through DayOne Tech’s acceleration program in the canton of Jura on August 17. According to a press release, they are CNS TherapyMoonlight AI, and CryoThermo 4.0. They will gain access to coaching, the ecosystem, office space, and funds. The healthcare innovation initiative from Basel Area Business & Innovation, an investment and innovation promotion agency, brings together professionals and specialists from various disciplines and companies in the Basel Area to strengthen the healthcare ecosystem and make it more sustainable.

Three startups selected

CNS Therapy from Zug has developed a treatment for chronic pain without medication, surgery, or implants. Its systolic extinction therapy, for example, using neuromodulation and behavioral therapy has been proven effective in randomized studies. It is an innovative, interactive behavioral therapy combined with a patented medical device.

Moonlight AI with headquarters at the Switzerland Innovation Park Basel Area – Jura in Courroux in the Swiss canton of Jura develops artificial intelligence models to predict genomic biomarkers that are therapeutically relevant. It uses scans of stained hematology or pathology slides to do so. The startup aims to use these to democratize access to genomic information for therapeutic decisions.

CryoThermo 4.0 is developing a new generation of patented medical thermal compresses “thanks to a technological and therapeutic paradigm shift”. The startup also plans to manufacture and market these. The aim is to become the global leader in this area.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More